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A B S T R A C T
Purpose: To determine efﬁcacy and safety of photic stimulation (PS) during electroencephalography
(EEG) in a large group of adult and paediatric patients.
Methods: A prospective multicentre National Service Evaluation was performed organised by the joint
audit committee of the two UK professional organisations (Association of Neurophysiological Scientists
and British Society for Clinical Neurophysiology). Questionnaires about every EEG performed in the two-
month study period were completed contemporaneously by physiologists at the time of the recording-
reporting. The occurrence during PS of photoparoxysmal responses (PPRs), seizures and psychogenic
non-epileptic attacks was noted from the EEG trace and contemporary clinical observation backed up by
the video that was synchronised with the EEG. 5383 patients investigated with EEG and PS, mostly for
possible epilepsy, were included in the study.
Results: Seventy nine patients (1.5%) had a generalised PPR elicited by PS having had no generalised
epileptiform discharges previously in the EEG. Thirty nine patients (0.7%) had seizures provoked by PS
including two (0.04%) who had a generalised tonic clonic seizure (GTCS). Forty nine patients (0.9%) had
non-epileptic attacks provoked by PS. Thus PS yielded potentially useful information (PPRs, seizures or
non-epileptic attacks) in 167/5383 (3.1%) of patients. In a subset of 122/5383 (2.3%), PS provided the only
useful information captured within the EEG.
Conclusion: PS contributes to the diagnosis of epilepsy and non-epileptic attack disorder in 3.1% of
patients. It is a safe technique which produces GTCSs in only 0.04% patients. We conclude that PS is a
moderately useful activation technique in diagnostic EEG, where the potential beneﬁts out-weigh the
risks; this information may assist the informed consent process.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Photic stimulation (PS) is widely used in routine video-EEG and
can contribute to the management of patients suspected of having
epilepsy. It may aid the diagnosis of epilepsy, support and refute
speciﬁc epileptic syndromes, help predict the likelihood of seizure
recurrence and allow the referring physician to counsel the patient
on environmental factors that might provoke photosensitive* Corresponding author. +44 0 2076793533.
E-mail address: k.whitehead@ucl.ac.uk (K. Whitehead).
http://dx.doi.org/10.1016/j.seizure.2015.11.005
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reseizures. Useful information can be provided in two ways, ﬁrst
by provoking epileptiform discharges referred to by convention as
photoparoxysmal responses (PPRs) and second, it may trigger
epileptic seizures and psychogenic non-epileptic attacks (NEAs).
The aim is to gain electrographic data without triggering
generalised tonic clonic seizures (GTCSs) because of the associated
risks to the patient.
The GMC consent guidance [1] emphasises the need for patients
to be properly informed prior to consenting to clinical procedures.
Because PS is a common procedure and because it is recommended
as part of a standard EEG [2–4] it is important to quantify as far as is
practicable the risks and potential beneﬁts (safety and efﬁcacy) ofserved.
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Fig. 1. Ages of 5383 patients who underwent PS.
Table 1
Demographic data.
Photic
Stimulation
No Photic
Stimulation
Demographic data from
6807 patients undergoing
routine EEG
Number of patients 5383 1424
Mean age in years (range) 30 (<1–99) 45 (<1–99)
% Sex F:M 49:51 48:52
No. (%) taking AEDs 1353 (25%) 266 (19%)
Referral diagnosis from
6807 patients
undergoing routine EEGa
Epilepsy 4420 (82%) 1054 (74%)
NEAD 133 (3%) 22 (4%)
Epilepsy and/or NEAD 258 (5%) 60 (2%)
Other 560 (10%) 283 (20%)
a Referral diagnosis missing in 5/1420 who did not undergo PS and in 12/5383
who underwent PS.
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their giving or withholding consent. In this case the main risks are
precipitating seizures and the main beneﬁts accrue from diagnos-
tic information. Unfortunately, data from large-scale series about
safety and efﬁcacy are sparse. In 20,000 cases collected over eleven
years [5] PPRs were reported in 225 cases un-associated with
accompanying ‘‘convulsions’’ and in a further 25 cases ‘‘convul-
sions’’ were induced by PS. In a more recent retrospective series
ﬁve cases of myoclonic jerks and one of dizziness and distress from
732 undergoing PS were reported [6].
The current National Service Evaluation described in this paper
was designed to determine the efﬁcacy of PS in producing
diagnostically useful data, and provide data on the safety of the
procedure from a large, national population of adult and paediatric
patients. The participating bodies (Association of Neurological
Scientists and British Society for Clinical Neurophysiology)
represent professionals providing EEG services in every major
department in the UK.
2. Methods
Eighty three departments were invited to participate in the
study (see Appendix A). Sixty eight (82%) departments
responded. Questionnaires (see Appendix B) were completed
for all adult and paediatric patients attending for routine (not
sleep-deprived) EEG between the 1st November and 31st
December 2013 inclusive so that there was no selection bias
in the questionnaires returned for analysis. Sleep-deprived
recordings were not included because sleep deprivation has a
facilitating effect on PPRs [7] and can be considered an
activation technique in its own right.
Questionnaires were completed by the recording clinical
physiologist at the time of the EEG and registered details about
each patient, including their referral diagnosis and whether PS was
performed. As can be seen from the questionnaire (Appendix B),
detailed Information about the PS procedure, the make, model and
characteristics of the photic stimulators used was not collected.
Referral diagnoses other than epilepsy or non-epileptic attack
disorder (NEAD) such as neurodegenerative diseases could be
captured on the questionnaire.
In the case of NEAD, the questionnaire did not record whether
or not the referring doctor requested an attempt to elicit a NEA.
If PS was not performed, physiologists were required to specify
a reason. Exclusions such as ‘too old’ were based on local protocols
that have been separately surveyed [8].
Physiologists registered a ‘Yes’ or ‘No’ if a PPR (without
discernible clinical changes) occurred. The cases with discernible
clinical changes associated with PS were classiﬁed by the
physiologist at the time of the video-EEG as either a seizure or a
NEA. For the purposes of the study, we broadly deﬁned seizures as
clinical neurological events with an EEG correlate, even if brief (e.g.
myoclonic jerks). These were subsequently further subdivided as
far as was practicable into seizure types. NEAs were not subdivided
into semiological categories.
With regard to electrographic events produced by PS, the
questionnaire was designed to identify speciﬁed electrographic
changes i.e. ‘‘unequivocal generalised epileptiform interictal EEG
activity (i.e. a Type III or IV photoparoxysmal response) NOT seen
in the resting record.’’ All references to a PPR in this paper describe
instances of Waltz et al. [9] Type III/IV. The higher grade response,
particularly grade IV, is associated with a greater tendency towards
seizures [10–12].
Information on the speciﬁc PS protocol was not collected. The
data were analysed using Microsoft Access and Excel and IBM SPSS
version 19.Ethical approval is not a requirement for the service evaluation
of routine clinical practice (UK NHS National Research Ethics
Service guidelines), nevertheless the project was registered as a
service evaluation with Shefﬁeld Teaching Hospitals NHS Trust
Clinical Effectiveness Unit.
3. Results
3.1. Demographics of those that did or did not undergo PS
PS was included in the EEG examination of 5383 patients (79%)
from a total of 6807 undergoing routine EEG. The 5383 patients
that underwent PS included 2061 children (17 years of age). In
the 1277 patients for whom a reason for excluding PS was
provided, the most commonly given reasons were: the patient was
‘‘too old’’ in 290 (23%), showed ‘‘insufﬁcient cooperation’’ in 235
(18%), was ‘‘too young’’ in 120 (9%) and ‘‘patient refused’’ in 84 (7%).
Those who did not undergo PS were older than those who did and
PS was performed more frequently in patients referred with
epilepsy and/or NEAD than for other diagnoses (Figs. 1 and 2;
Table 1).
3.2. Efﬁcacy: Evoking PPRs
A PPR occurred in the EEGs of 79 of 5383 cases that underwent
PS (1.5%), being the ﬁrst instance of an interictal epileptiform EEG
feature in the terms deﬁned by the project protocol. The referral
diagnosis in cases whose EEGs contained PPRs was epilepsy in
75 cases, NEAD in 2 cases, epilepsy plus NEAD in 1 case and ‘other’
in 1 case.
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Fig. 2. Percentage of EEGs which included PS.
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Fig. 3. Percentage of elicited PPRs, activation of seizures and activation of NEAs by
age groups.
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In 39 cases (0.7%) seizures occurred in association with PS. The
seizure type in 36 (92.3%) was ‘‘generalised’’ and it was ‘‘focal’’ in
the remaining 3 (7.7%). The 36 cases with ‘‘generalised’’ seizures
were further classiﬁed as myoclonus (17), absences (11), eyelid
myoclonia (3), GTCS (2), myoclonic absence (1), atonic (1), eyelid
ﬂicker without loss of awareness (1). One focal seizure was
described as ‘‘focal myoclonus’’ while the other two patients’
seizures were described as ‘‘focal myoclonus/spasm’’.
In 16 (41%) of the 39 cases, a seizure had been noted as
occurring in the resting or hyperventilation parts of the record by
the physiologist (Fig. 4). In 23 of the 39 cases (59%) no seizure had
been observed by the physiologist prior to PS. Consequently, PS
more than doubled the tally of seizures that could be recorded.
3.4. Efﬁcacy: Non-epileptic attacks
Forty nine patients (0.9%) had NEAs triggered by PS. In 29 of
these 49 cases, the patient was referred with suspected NEAD. In
13 of these 29 cases (45%) there had already been a NEA prior to PS
(Fig. 4). But in the remaining 16 cases (55%) PS was effective in
eliciting a properly witnessed and recorded attack that would
otherwise not have been seen.
3.5. Efﬁcacy: Age
The relationship between age and the incidence of seizures,
PPRs and NEAs is illustrated in Fig. 3. The age range of cases with
seizures was between 2 and 67 years (mean 17 years; medianDurin g PS in  5383 p
39 had se izure  49 had NEA
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23/39  new  
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Fig. 4. Efﬁcacy of PS in yiel13 years). The age range of cases with NEAs was between 9 and
71 years (mean 35 years; median 32 years). The age range of cases
with PPRs was between 1 and 65 years, (mean 19 years; median
15 years).
3.6. Efﬁcacy: AED use
A minority, 1353, (25%) of the 5383 cases were medicated with
AEDs. PPRs without a seizure occurred in 18 medicated cases (1.3%)
and PPRs associated with a seizure occurred in the remaining
10 cases (0.7%). The majority, 4030, (75%) of cases were not
medicated with AEDs. PPRs without a seizure occurred in 61 un-
medicated cases (1.5%) and PPRs occurred with a seizure in the
remaining 29 un-medicated cases (0.7%).
The data in the above paragraph suggest that medication has
not inﬂuenced the occurrence of PPRs or seizures within the
limitations of this study sample. Chi-squared test shows that there
is no relationship between whether the patient is taking AEDs and
whether they had a PPR (p = 0.628) or a seizure (p = 0.942).
3.7. Efﬁcacy: Overall
In 167 (3.1%) cases PS elicited a PPR or a seizure or a non-
epileptic attack. In 122 cases (2.3%), PS contributed the deﬁnitive
information to support a diagnosis of epilepsy or NEAD (Fig. 4). The
122 cases include 72 with a PPR (no seizure during PS), and 50 with
a seizure or NEA elicited by PS, in which there had been no attack in
the preceding resting or hyperventilation EEG. In the remainingaents 
7/79 seizur e 
previousl y in  EEG 
7/49  new  
NEA 
y us eful 
G in  122 
79 had PPR (no int ericta l epil epform 
discharge in  RR/H V)
72/79  no  seizu re
ding new information.
Table 2
Incidence of clinical attacks and PPRs during EEG in all 5383 patients.
Pre-test
diagnosis
Attack
prior
to PS
(n = 403)
Attack provoked by
PS (n = 88)
PPR provoked by
PS (n = 79)
Epileptic
seizure
(n = 39)
NEA (n = 49)
Epilepsy
(4420)
308 33 17 75
NEAD
(133)
26 2 15 2
Epilepsy and/
or NEAD
(258)
45 2 14 1
Other (560) 24 2 3 1
K. Whitehead et al. / Seizure 34 (2016) 29–343245 cases (Fig. 4) there had already been a clinical attack prior to PS;
in this eventuality, the outcome of the EEG was likely to have been
decisive without employing PS.
3.8. Safety: GTCSs provoked by PS
GTCS occurred in 2 cases (0.04%) out of the 5383 cases in the
study i.e. 1:2692 cases. The patients were a female aged 13 years
and a male aged 25 year; both were taking AEDs. Both GTCSs
resolved spontaneously and neither patient required admission to
the ward.
4. Discussion
The purpose of this study was to provide evidence on the safety
and efﬁcacy of photic stimulation in routine clinical practice, based
on data collected prospectively from a large number of clinical
neurophysiology departments. The main risk (that was to be
quantiﬁed) was epileptic seizures, particularly GTCSs. The poten-
tial beneﬁt of PS was expected to arise from improved diagnostic
precision.
4.1. PPRs
In the current study, 79 cases (1.5%) developed a PPR without a
seizure (Fig. 4). This is similar to the ﬁndings of Wadlington and
Riley [5]. Of their 20,000 cases, 225 (1.1%) developed PPRs. (It
should be noted that in the current study, PPRs were only reported
if the preceding parts of EEG had been free of inter-ictal
epileptiform discharges, to avoid interpretative confusion). In a
study of 1000 cases from a tertiary referral centre, 732 of which
underwent PS, 16 (2.2%) exhibited Type IV (Waltz et al.) changes in
the EEG; 11 had inter-ictal epileptiform discharges in the previous
parts of the EEG [6].
In a study that included 1267 cases undergoing PS, ‘‘Epilepti-
form responses’’ were reported in 42 (3.3%) [21].
4.2. Seizures
In the current study, 39 cases (0.7%) had a seizure triggered by
PS, but there were only 2 cases (0.04%) of GTCSs evoked during PS.
In the series published by Wadlington and Riley [5], the seizure
type induced by PS is only stated for a small number of illustrative
cases. However, based on these authors’ terminology of ‘overt
convulsions’, the seizure type is likely to have been GTCS in the
majority of instances, with an overall incidence of 0.13% (from an
inspection of the sample of case reports that were published). The
higher incidence in their study is likely to reﬂect differing, arguably
less constrained, stimulus protocols. No cases of GTCS occurred in
the 732 reported by Angus-Leppan [6], probably because of the
small sample size.
4.3. NEAs
NICE guidelines (CG 137, 2012) do not recommend the use of
EEG to exclude a diagnosis of epilepsy if the clinical presentation
points to NEAD (1.6.7). However, the presenting diagnosis of NEAD
may be a partial picture as in the four cases in this series referred
with a diagnosis of NEAD (Table 2) in which there was a PPR during
PS.
NICE guidelines also mention that ‘provocation by suggestion’
[such as in association with PS] may lead to false-positive
conclusions. This risk can be minimised if the attacks and
concurrent EEG are accompanied by high quality video and re-
montaged to improve identiﬁcation of artefact. With these
provisos, PS can usefully enhance the diagnostic potential of theEEG. The SIGN epilepsy guideline supports this and advises the use
of suggestion for the diagnosis of suspected NEAD (143) [20].
In this series, PS was able to support the proffered diagnosis of
NEAD in 29 of 391 referrals (7.4%) who had a NEA during PS. In
16 of these 29 patients (4% of the 391 referrals), this was the only
attack captured (with none having previously occurred in the
resting or hyperventilation parts of the record). In addition,
17 patients in this series who were referred with a diagnosis of
epilepsy had a NEA during PS (Table 2).
Previous studies [13,14] focussed on PS, HV and ‘‘suggestion’’ in
combination for evoking NEAs (yield 67–84%). Neither of these
papers differentiated the yield from PS alone. The present study,
together with the recent paper by the National Audit Group on HV
[15], helps to distinguish the effectiveness of these two provoca-
tion techniques individually in relation to NEAs. The yield for the
two procedures analysed separately, in two different case
populations, has turned out to be 0.9% in both Kane et al.’s and
this study.
4.4. Age
In the current study, the median age at which seizures and PPRs
occurred was 13 and 15 years respectively; for PPRs this is slightly
higher than the 12 years of age for PPRs reported by Harding and
Jeavons [16]. Twenty cases (4.4%) from the above mentioned
authors had PPRs persisting above the age of 30 years, a ﬁnding
echoed in this study.
PS was omitted because patients were ‘too old’ from their 5th
decade onwards. However, the oldest patient having a NEA was
71 years old highlighting potential missed opportunities to
capture NEAs.
4.5. AEDs
AEDs have been reported to reduce the occurrence of PPRs.
Harding et al. [17] found that PPRs were abolished by AEDs in
27 of 50 photosensitive subjects, with an attenuation of
sensitivity in a further 12. However, no effect of AEDs on the
incidence of a PPR or seizures was apparent in the current study.
This ﬁnding should be interpreted with caution, primarily
because the two study groups had different selection criteria.
The Harding study speciﬁcally included cases of known
sensitivity to xenon ﬂash, whereas the current study is from
an unselected cohort.
4.6. Constraints
In the current study PPRs were only documented when no
epileptiform discharges had occurred in the EEG prior to PS. This
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obtained from performing PS, but we have, through this constraint,
probably missed describing some instances where the presence of
a PPR might have helped in epilepsy classiﬁcation, elucidation of an
epileptic syndrome, and perhaps the ability to counsel the patient
regarding safety. Therefore, the estimate in this study of the
usefulness of PS in EEG is likely to be a slight under-estimate.
Recording detailed information about captured NEAs was beyond
the scope of the present study and is the subject of an on-going
national service evaluation.
Information on the PS protocol used was not collected, so the
effect of protocol variation on the diagnostic yield from PS [18]
cannot be ascertained. This is a domain with many variables and
no comprehensive scientiﬁc evidence base. A related study has
shown that UK practice is varied [8], leading to the recent
formulation of ANS-BSCN national standards [19]. Expert groups
have rationalised the process of photic stimulation in clinical
practice, but they have been unable to arrive at a consensus for
every detail of the procedure (Harding personal communica-
tion). Consequently variation in practice is not unexpected even
though it may need justiﬁcation. The phasing out of xenon
discharge tubes in favour of LED stimulators was completely
uncontrolled and is an example of the difﬁculties of rationalizing
practice.
5. Conclusion
Photic stimulation elicited useful diagnostic ﬁndings in 3.1% of
cases; in 2.3% cases this was the only part of the EEG process that
elicited diagnostically helpful information.
The risk of inducing a GTCS was 0.04% (1 in 2692) i.e. the seizure
type most likely to be associated with clinical harm to the patient.
The need for the procedure to be carried out in a properly
controlled environment is self evident.
All seizures may have implications for employment, driving and
the patient’s conﬁdence and dignity, emphasising the need for
properly informed and monitored continuing consent.
We conclude that the study has provided reliable data to inform
the consent process for this valuable procedure. Patients can use
the data from this study to decide whether the risk vs. beneﬁt ratio
is acceptable.
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Appendix B. Form B
Postcode of centre (Please complete): Local EEG number (Please complete):
1. What is the age of the patient?
2. What is the gender of the patient? M/F
3. What was the referral diagnosis? Epilepsy
Non-Epileptic Attack Disorder (NEAD)
Epilepsy and/or NEAD
Other
4. Did a clinical attack occur spontaneously during the resting record or provoked by Hyperventilation (HV)? Yes/No
5. Was Photic Stimulation (PS) performed?
If ‘yes’ proceed to question 7 and continue the questionnaire
If ‘no’ answer question 6 only
Yes/No
6. Why was Photic Stimulation not performed? Previously demonstrated photosensitivity
Age: patient too old for PS to be valuable
Age: patient too young to cooperate
Insufﬁcient cooperation from patient
Sleep deprived
Patient refused
Against dept protocol (not listed above)
Other
7. How long after the end of HV was PS performed (in minutes)?
8. Did PS provoke a clinical seizure? Yes/No
9. If ‘yes’ was it:
If ‘Epileptic’ please answer questions 10, 11 and 12.
If ‘Non- Epileptic’ please proceed to question 12
An Epileptic seizure
A Non-Epileptic Attack
10. If an Epileptic seizure was precipitated by PS was it: Generalised
Focal
11. Please describe precise Epileptic seizure type: Generalised Tonic Clonic Seizure
Generalised (limb or body) Myoclonus
Eyelid Myoclonus
Absence
Other (please state)
Unclassiﬁed
12. Did Photic stimulation produce unequivocal generalised epileptiform interictal EEG activity
(i.e. a Type III or IV Photoparoxysmal response) NOT seen in the resting record?
Yes/No
13. Is the patient currently taking Anti-Epileptic Drugs? Yes/No
K. Whitehead et al. / Seizure 34 (2016) 29–3434References
[1] General Medical Council. Consent: patients and doctors making decisions
together; 2013, hhttp://www.gmc-uk.org/guidance/ethical_guidance/consent_
guidance_index.aspi (accessed 23/08/2015).
[2] International League Against Epilepsy, Flink R, Pedersen B, Guekht AB, Mal-
mgren K, Michelucci R, et al. Guidelines for the use of EEG methodology in the
diagnosis of epilepsy. Acta Neurol Scand 2002;106:1–7.
[3] National Institute for Health and Clinical Excellence. The epilepsies: the
diagnosis and management of the epilepsies in adults and children in primary
and secondary care. NICE CG; 2012. 137.
[4] American Clinical Neurophysiology Society. Guideline one: minimum techni-
cal requirements for performing clinical electroencephalography. J Clin Neu-
rophysiol 2006;23:86–91.
[5] Wadlington WB, Riley Jr HD. Light-induced seizures. J Pediatr 1965;66:300–12.
[6] Angus-Leppan H. Seizures and adverse events during routine scalp electroen-
cephalography: a clinical and EEG analysis of 1000 records. Clin Neurophysiol
2007;118:22–30.
[7] Scollo-Lavizzari G, Scollo-Laviazzari GR. Sleep, sleep deprivation, photosensi-
tivity and epilepsy. Eur Neurol 1974;11:1–21.
[8] Lawrence S, Kandler R, Whitehead K, Sherratt M, Pang C. Clinical governance
results of a national service evaluation on the safety and efﬁcacy of photic
stimulation during EEG. J Assoc Neurophysiol Sci 2015;8:14–21.
[9] Waltz S, Christen HJ, Doose H. The different patterns of the photoparoxysmal
response. Electroencephalogr Clin Neurophysiol 1992;83:138–45.
[10] Quirk JA, Fish DR, Smith SJ, Sander JWAS, Shorvon SD, Allen PJ. First seizures
associated with playing electronic screen games: a community-based study in
Great Britain. Ann Neurol 1995;37:733–7.
[11] Kasteleijn-Nolst Trenite´ DGA, Binnie CD, Harding GFA, Wilkins A. Photic
stimulation: standardization of screening methods. Epilepsia 1999;40:75–9.[12] Reilly EL, Peters JF. Relationship of some varieties of electroencephalographic
photosensitivity to clinical convulsive disorders. Neurology 1973;23:
1050–7.
[13] Benbadis SR, Johnson K, Anthony K, Caines G, Hess G, Jackson C, et al. Induction
of psychogenic non-epileptic seizures without placebo. Neurology 2000;55:
1904–5.
[14] McGonigal A, Oto M, Russell AJC, Greene J, Duncan R. Outpatient video EEG
recording in the diagnosis of non-epileptic seizures: a randomised controlled
trail of simple suggestion techniques. J Neurol Neurosurg Psychiatry
2002;72:549–51.
[15] Kane N, Grocott L, Kandler R, Lawrence S, Pang C. Hyperventilation during
electroencephalography: safety and efﬁcacy. Seizure 2014;23:129–34.
[16] Harding GFA, Jeavons PM. Photosensitive epilepsy. London: Mac Keith Press;
1994.
[17] Harding GFA, Herrick CE, Jeavons PM. A controlled study of the effect of
sodium valproate on photosensitive epilepsy and its prognosis. Epilepsia
1978;19:555–65.
[18] Kasteleijn-Nolst Trenite´ D, Rubboli G, Hirsch E, Martins da Silva A, Seri S,
Wilkins A, et al. Methodology of photic stimulation revisited: updated Euro-
pean algorithm for visual stimulation in the EEG laboratory. Epilepsia
2012;53:16–24.
[19] ANS/BSCN. Guidelines for photic stimulation during EEG recordings; 2015,
hhttp://www.bscn.org.uk/con-
tent.aspx?Group=guidelines&Page=guidelines_photic%20stimulation%20dur-
ing%20eegi (accessed 10th October 2015).
[20] Healthcare Improvement Scotland. Diagnosis and management of epilepsy in
adults; May 2015, hhttp://www.sign.ac.uk/pdf/SIGN143.pdfi (accessed 10th
October 2015) SIGN 143.
[21] Hughes JR, Curtin MJ, Brown VP. Usefulness of photic stimulation in routine
clinical electroencephalography. Neurology 1960;10:777–82.
